Thu, May 31, 2018
Wed, May 30, 2018
Tue, May 29, 2018
Fri, May 25, 2018
Thu, May 24, 2018
Wed, May 23, 2018
Tue, May 22, 2018
Mon, May 21, 2018
Fri, May 18, 2018
Thu, May 17, 2018
Wed, May 16, 2018
Tue, May 15, 2018
Mon, May 14, 2018
Fri, May 11, 2018
Thu, May 10, 2018
Wed, May 9, 2018
Tue, May 8, 2018
Mon, May 7, 2018
Fri, May 4, 2018
Thu, May 3, 2018

David Nierengarten Upgraded (VYGR) to Buy on, May 11th, 2018


//stocks-investing.news-articles.net/content/201 .. arten-upgraded-vygr-to-buy-on-may-11th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


David Nierengarten of Wedbush, Upgraded "Voyager Therapeutics, Inc." (VYGR) to Buy on, May 11th, 2018.

David has made no other calls on VYGR in the last 4 months.



There are 3 other peers that have a rating on VYGR. Out of the 3 peers that are also analyzing VYGR, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Josh Schimmer of "Evercore ISI Group" Downgraded from Buy to Hold on, Monday, March 12th, 2018


These are the ratings of the 2 analyists that currently disagree with David


  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $35 on, Thursday, March 15th, 2018
  • Jeffrey Hung of "Morgan Stanley" Maintained at Buy with Increased Target to $39 on, Wednesday, February 21st, 2018

Publication Contributing Sources